Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Cancer Cell
|
February 15, 2014
Molecular subtyping of invasive bladder cancer: time to divide and rule?
Carolyn D Hurst, Margaret A Knowles
Nature Reviews. Clinical Oncology
|
December 20, 2017
Bladder cancer: Multi-omic profiling refines the molecular view
Carolyn D Hurst, Margaret A Knowles
Nature Reviews. Cancer
|
December 24, 2014
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A Knowles, Carolyn D Hurst
Urologic Oncology
|
November 18, 2018
Mutational landscape of non-muscle-invasive bladder cancer
Carolyn D Hurst, Margaret A Knowles
Human Molecular Genetics
|
November 24, 2012
Oncogenic FGFR3 gene fusions in bladder cancer
Sarah V Williams, Carolyn D Hurst, Margaret A Knowles
European Urology
|
September 17, 2013
Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine
Carolyn D Hurst, Fiona M Platt, Margaret A Knowles
Scientific Reports
|
April 7, 2019
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
Erica di Martino, Olivia Alder, Carolyn D Hurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2012
Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis
Carolyn D Hurst, Fiona M Platt, Claire F Taylor, et al.
Cancer Metastasis Reviews
|
December 17, 2009
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
Margaret A Knowles, Fiona M Platt, Rebecca L Ross, et al.
Oncogene
|
February 18, 2004
High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization
Carolyn D Hurst, Heike Fiegler, Philippa Carr, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Cancer Cell
|
February 15, 2014
Molecular subtyping of invasive bladder cancer: time to divide and rule?
Carolyn D Hurst, Margaret A Knowles
Nature Reviews. Clinical Oncology
|
December 20, 2017
Bladder cancer: Multi-omic profiling refines the molecular view
Carolyn D Hurst, Margaret A Knowles
Nature Reviews. Cancer
|
December 24, 2014
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A Knowles, Carolyn D Hurst
Urologic Oncology
|
November 18, 2018
Mutational landscape of non-muscle-invasive bladder cancer
Carolyn D Hurst, Margaret A Knowles
Human Molecular Genetics
|
November 24, 2012
Oncogenic FGFR3 gene fusions in bladder cancer
Sarah V Williams, Carolyn D Hurst, Margaret A Knowles
European Urology
|
September 17, 2013
Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine
Carolyn D Hurst, Fiona M Platt, Margaret A Knowles
Scientific Reports
|
April 7, 2019
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
Erica di Martino, Olivia Alder, Carolyn D Hurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2012
Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis
Carolyn D Hurst, Fiona M Platt, Claire F Taylor, et al.
Cancer Metastasis Reviews
|
December 17, 2009
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
Margaret A Knowles, Fiona M Platt, Rebecca L Ross, et al.
Oncogene
|
February 18, 2004
High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization
Carolyn D Hurst, Heike Fiegler, Philippa Carr, et al.
Page
of 4